Name | VAMIMED, OOO |
|---|
INN | 0711026920 |
|---|
KPP | 072501001 |
|---|
OGRN | 1020700751609 |
|---|
OKPO | 31843270 |
|---|
Address | 360051, respublika Kabardino-balkarskaya, g. Nal'chik, ul. Lermontova, d. D.20 |
|---|
Phone | 42-45-75 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 09.12.2002 |
|---|
Registering department | Departament po upravleniyu gorodskim imuschestvom |
|---|
|
VAMIMED, OOO (Kabardino-Balkar Republic; INN 0711026920) was registered on 9 Dec 2002. The company's authorized capital as of July 1, 2012 was 95506 rub. Type of ownership of VAMIMED, OOO - Limited liability companies. Form of ownership of VAMIMED, OOO - Private property. Principal activities of VAMIMED, OOO: retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net profit (RAS) of VAMIMED, OOO grew over 2023 by 28.31% to 6.34 million RUB from 4.94 million RUB over 2022, the company informed. Revenue decreased in the accounting period by 1.77% to 102.97 million RUB from 104.83 million RUB in 2022; cost of goods sold decreased by 4.24% to 94.40 million RUB from 98.58 million RUB; sales profit went up by 37.27% to 8.58 million RUB from 6.25 million RUB. 2022
Net profit (RAS) of VAMIMED, OOO dropped in 2022 by 4.85% to 4.94 million RUB from 5.19 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 7.84% to 104.83 million RUB from 113.75 million RUB in 2021; cost of goods sold decreased by 7.41% to 98.58 million RUB from 106.47 million RUB; sales profit fell by 14.21% to 6.25 million RUB from 7.28 million RUB. 2021
Net profit (RAS) of VAMIMED, OOO grew over 2021 by 23.08% to 5.19 million RUB from 4.22 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 4.44% to 113.75 million RUB from 119.03 million RUB in 2020; cost of goods sold decreased by 5.60% to 106.47 million RUB from 112.79 million RUB; sales profit went up by 16.59% to 7.28 million RUB from 6.25 million RUB. 2020
Net profit (RAS) of VAMIMED, OOO grew over 2020 4.17 times to 4.22 million RUB from 1.01 million RUB over 2019, the company informed. Revenue increased in the accounting period by 26.10% to 119.03 million RUB from 94.40 million RUB over 2019; cost of goods sold grew by 29.70% to 112.79 million RUB from 86.96 million RUB; sales profit went up 2.74 times to 6.25 million RUB from 2.28 million RUB. 2018
Net profit (RAS) of VAMIMED, OOO dropped in 2018 2.99 times to 1.02 million RUB from 3.04 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period 2.08 times to 88.26 million RUB from 42.38 million RUB over 2017; cost of goods sold grew 2.23 times to 86.41 million RUB from 38.68 million RUB; sales profit fell 2.00 times to 1.85 million RUB from 3.70 million RUB. 2017
Net profit (RAS) of VAMIMED, OOO dropped in 2017 by 16.65% to 3.04 million RUB from 3.65 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 7.15% to 42.38 million RUB from 45.64 million RUB in 2016; cost of goods sold decreased by 6.47% to 38.68 million RUB from 41.35 million RUB; sales profit fell by 13.69% to 3.70 million RUB from 4.29 million RUB. 2016
Net profit (RAS) of VAMIMED, OOO dropped in 2016 by 16.70% to 3.65 million RUB from 4.38 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 6.59% to 45.64 million RUB from 48.86 million RUB in 2015; cost of goods sold decreased by 6.11% to 41.35 million RUB from 44.04 million RUB; sales profit fell by 11.00% to 4.29 million RUB from 4.82 million RUB. 2014
Net profit (RAS) of VAMIMED, OOO dropped in 2014 by 24.64% to 7.70 million RUB from 10.22 million RUB over the same period in 2013, the company informed. Revenue decreased in the accounting period by 6.63% to 51.77 million RUB from 55.45 million RUB in 2013; cost of goods sold decreased by 2.90% to 43.84 million RUB from 45.15 million RUB; sales profit fell by 23.02% to 7.93 million RUB from 10.30 million RUB. 2013
Net profit (RAS) of VAMIMED, OOO dropped in 2013 by 4.14% to 10.22 million RUB from 10.66 million RUB over the same period in 2012, the company informed. Revenue decreased in the accounting period by 6.56% to 55.45 million RUB from 59.35 million RUB in 2012; cost of goods sold decreased by 7.82% to 45.15 million RUB from 48.98 million RUB; sales profit fell by 0.59% to 10.30 million RUB from 10.36 million RUB. 2012
Net profit (RAS) of VAMIMED, OOO dropped in 2012 by 22.43% to 10.66 million RUB from 13.74 million RUB over the same period in 2011, the company informed. Revenue decreased in the accounting period by 40.31% to 59.35 million RUB from 99.43 million RUB in 2011; cost of goods sold decreased by 43.10% to 48.98 million RUB from 86.08 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|